Driving Product Success: Navigating the Clinical to Commercial Transition for Autologous Therapies

There are more than 1,300 active cell therapy trials. In this article from Cell & Gene, Andrea Zobel, Senior Director, Personalized Supply Chain, joins Melissa Lattanzi from AmerisourceBergen and Jason Ramseth from TrakCel to discuss the best approach to bring autologous cell therapies to market. From the key components of a commercial strategy to the existing solutions enabling supply chain partners to establish a comprehensive chain of custody, the article covers the necessary steps to navigate the challenges of moving from clinical to commercial development.